Description | This product is a monoclonal antibody derived from Human (Homo sapiens), which can specifically recognize CD83 molecule. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation. Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free. |
Clonality | Monoclonal |
Host Species | Human |
Target Species | Human |
Isotype | IgG1, κ |
Expression Species | HEK293F or CHO |
Conjugation | None |
Purity | >95%, determined by SDS-PAGE and/or SEC-HPLC |
Endotoxin | <1 EU/mg, determined by LAL method |
Purification | Protein A affinity purified |
Sterility | 0.2 μM filtered |
Formulation | PBS, pH 7.4 |
Preservation | No preservatives |
Stabilizer | No stabilizers |
Storage | Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C. |
Application | WB; SPR |
Application Notes | The antibody is recommended for detection of CD83 by WB, SPR assays. |
ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
WB | Western Blot Protocol |
FC | Flow Cytometry Protocol |
Figure 1 Recombinant Anti-CD83 Antibody (V3S-0522-YC5434) in Western Blot.
Western blot analysis of V3S-0522-YC5434 was performed by loading recombinant human CD83 protein.
TAB-353LC incubation concentration: 2 ng/μL.
The secondary antibody: HRP-goat anti-human IgG
Lane 1: Reduced antigen (0.6 μg)
Figure 1 Recombinant Anti-CD83 Antibody (V3S-0522-YC5434) in Western Blot.
Figure 2 Recombinant Anti-CD83 Antibody (V3S-0522-YC5434) in ELISA.
ELISA analysis of V3S-0522-YC5434 was performed by coating with recombinant human CD83 protein. Then blocked with BSA, and incubated with human anti-CD83 recombinant Antibody (V3S-0522-YC5434). The goat anti-human IgG-HRP as a secondary antibody. Detection was performed using TMB substrate and stopped with sulfuric acid. The absorbances were read on a spectrophotometer at 450 nm.
Figure 2 Recombinant Anti-CD83 Antibody (V3S-0522-YC5434) in ELISA.
Figure 3 Recombinant Anti-CD83 Antibody (V3S-0522-YC5434) Fab Fragment in Western Blot.
Western blot analysis of V3S-0522-YC5434-Fab was performed by loading recombinant human CD83 protein.
V3S-0522-YC5434-Fab incubation concentration: 2 ng/μL.
The secondary antibody: HRP-goat anti-human IgG
Lane 1: Reduced antigen (0.6 μg)
Figure 3 Recombinant Anti-CD83 Antibody (V3S-0522-YC5434) Fab Fragment in Western Blot.
Figure 4 Recombinant Anti-CD83 Antibody (V3S-0522-YC5434) Fab Fragment in ELISA.
ELISA analysis of V3S-0522-YC5434-Fab was performed by coating with recombinant human CD83 protein. Then blocked with BSA, and incubated with human anti-CD83 recombinant Antibody Fab fragment (V3S-0522-YC5434-Fab). The goat anti-human IgG-HRP as a secondary antibody. Detection was performed using TMB substrate and stopped with sulfuric acid. The absorbances were read on a spectrophotometer at 450 nm.
Figure 4 Recombinant Anti-CD83 Antibody (V3S-0522-YC5434) Fab Fragment in ELISA.